AWARENESS AMONG PEOPLE BASED ON NEURO ONCOLOGY

Аннотация

Limitations in trial design, accrual, and data reporting impact efficient and reliable drug evaluation in cancer clinical trials. These concerns have been recognized in neuro-oncology but have not been comprehensively evaluated. We conducted a semi- automated survey of adult interventional neuro-oncology trials, examining design, interventions, outcomes, and data availability trends. Trials were selected programmatically from ClinicalTrials.gov using primary malignant CNS tumour classification terms. Regression analyses assessed design and accrual trends; effect size analysis utilized survival rates among trials investigating survival. KEYWORDS Primary Central Nervous System malignancies; clinical trial design trends; trial accrual; treatment effect size assumptions; leveraging of trial registry data. Interdisciplinary; Iran; NOSC; brain tumours; neuro-oncology. Volume 03 Issue 05-2023 24 American Journal Of Biomedical Science & Pharmaceutical Innovation (ISSN – 2771-2753) VOLUME 03 ISSUE 05 Pages: 24-36 SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705) (2023: 6.534) OCLC – 1121105677 Publisher: Oscar Publishing Services Servi